Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Present And Forecasted Size Of The Preclinical Imaging Market?
There has been a significant expansion in the size of the preclinical imaging market in the past few years. The market, which is projected to be worth $3.46 billion in 2024, is expected to experience a growth to $3.69 billion in 2025. This represents a compound annual growth rate (CAGR) of 6.5%. The past growth of this market can be attributed to factors such as government initiatives, potentially increasing disease prevalence, the broadening of applications, heightened awareness, and progression into emerging markets.
Expectations are high for robust growth in the preclinical imaging market size in the coming years. It’s estimated to reach a value of $4.81 billion by 2029, advancing at a compound annual growth rate (CAGR) of 6.9%. This growth expected during the forecast period can be credited to the uptake of personalized medicine, progress in molecular imaging, outsourcing of drug development, support from regulatory bodies, and an increase in chronic illnesses. The predominant trends for this forecast period encompass green imaging technologies, technological progression, an escalation in R&D activities, cooperation and collaborations, and real-time imaging.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp
What Drivers Are Accelerating Expansion Of The Preclinical Imaging Market?
The escalation of chronic health conditions is predicted to stimulate the expansion of the preclinical imaging market. Chronic illnesses are enduring health conditions typically lasting for three months or longer, often requiring continuous medical care and having a significant effect on the person’s life quality. Preclinical imaging instruments are employed to identify such diseases by visualizing lung function and bone structure. This technique is also applied in chronic disease studies to determine disease progression, enhancing comprehension of the illness. To exemplify, the World Health Organization’s (WHO) 2022 Highlights, published in September 2022, show that a Switzerland-based intergovernmental health organization noted 41 million deaths globally each year, accounting for 74% of all deaths due to Noncommunicable or chronic diseases. The breakdown includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the rise in chronic diseases is a major factor contributing to the growth of the preclinical imaging market.
What Are The Primary Segmentation Parameters In The Preclinical Imaging Market?
The preclinical imagingmarket covered in this report is segmented â
1) By Modality: Optical Imaging Systems; Preclinical Nuclear Imaging Systems; Micro-Magnetic Resonance Imaging Systems; Micro-Ultrasound Systems; Micro-Computed Tomography Systems; Preclinical Photoacoustic Imaging Systems; Preclinical Magnetic Particle Imaging (MPI) Systems
2) By Reagents: Preclinical Optical Imaging Reagents; Preclinical Nuclear Imaging Reagents; Preclinical MRI Contrast Agents; Preclinical Ultrasound Contrast Agents; Preclinical CT Contrast Agents
3) By End User: Hospital; Diagnostics Center; Other End-User
Subsegments:
1) By Optical Imaging Systems: Bioluminescence Imaging; Fluorescence Imaging
2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET); Single-Photon Emission Computed Tomography (SPECT)
3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems; Functional Micro-MRI Systems
4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging; Real-Time Micro-Ultrasound Systems
5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems; Ex Vivo Micro-CT Systems
6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging; Hybrid Photoacoustic Imaging Systems
7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking; MPI For Vascular Imaging
Which Emerging Trends Are Reshaping The Preclinical Imaging Market Landscape?
A significant trend that has emerged in the preclinical imaging market is the introduction of groundbreaking products. Major players in this sector are crafting innovative solutions aimed at maintaining their market dominance. For instance, Fujifilm VisualSonics Inc., a Canada-based company that specializes in the production of imaging systems, unveiled Vevo F2 for preclinical imaging in May 2022. This game-changing product stands out as the premier preclinical imaging system straddling ultra-high to low frequencies (71 MHzâ1 MHz) in ultrasounds and photoacoustic imaging. The Vevo F2 is exceptional, thanks to its high-definition image processing technology and an entirely new signal pathway, which enhance image clarity and frame rate. The system is also adaptable to meet particular accuracy needs. Furthermore, it boasts robust attributes such as high-definition image processing technology, an entirely novel signal pathway, customizable system architecture, a vast variety of anatomical targets, and high-resolution imaging capabilities, making it applicable to diverse research fields.
Which Players Are Shaping The Competitive Landscape Of The Preclinical Imaging Market?
Major companies operating in the preclinical imaging market include Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report
What Are The Emerging Regional Trends Driving The Preclinical Imaging Market?
North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp
Browse Through More Reports Similar to the Global Preclinical Imaging Market 2025, By The Business Research Company
3D Medical Imaging Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/3d-medical-imaging-devices-global-market-report
Brain And Neuroimaging Devices Global Market Report 2025
Breast Imaging Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/breast-imaging-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model